Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kristina R Patterson

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|July 8, 2011
Pathogenic forms of tau inhibit kinesin-dependent axonal transport through a mechanism involving activation of axonal phosphotransferasesNicholas M Kanaan, Gerardo A Morfini, Nichole E LaPointe, et al.
The Journal of Biological Chemistry|May 10, 2011
Characterization of prefibrillar Tau oligomers in vitro and in Alzheimer diseaseKristina R Patterson, Christine Remmers, Yifan Fu, et al.
Neuroimage. Clinical|May 20, 2020
TAPAS: A Thresholding Approach for Probability Map Automatic Segmentation in Multiple SclerosisAlessandra M Valcarcel, John Muschelli, Dzung L Pham, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|September 10, 2004
Early N-terminal changes and caspase-6 cleavage of tau in Alzheimer's diseasePeleg M Horowitz, Kristina R Patterson, Angela L Guillozet-Bongaarts, et al.
Annals of Clinical and Translational Neurology|September 2, 2024
B cell and aquaporin-4 antibody relationships with neuromyelitis optica spectrum disorder activityJeffrey L Bennett, Sean J Pittock, Friedemann Paul, et al.
Annals of Clinical and Translational Neurology|October 7, 2023
Inebilizumab reduces neuromyelitis optica spectrum disorder risk independent of FCGR3A polymorphismHo Jin Kim, Orhan Aktas, Kristina R Patterson, et al.
Nature Medicine|September 15, 2021
Cellular and humoral immune responses following SARS-CoV-2 mRNA vaccination in patients with multiple sclerosis on anti-CD20 therapySokratis A Apostolidis, Mihir Kakara, Mark M Painter, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 12, 2023
Differential effects of anti-CD20 therapy on CD4 and CD8 T cells and implication of CD20-expressing CD8 T cells in MS disease activityKoji Shinoda, Rui Li, Ayman Rezk, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|July 8, 2011
Pathogenic forms of tau inhibit kinesin-dependent axonal transport through a mechanism involving activation of axonal phosphotransferasesNicholas M Kanaan, Gerardo A Morfini, Nichole E LaPointe, et al.
The Journal of Biological Chemistry|May 10, 2011
Characterization of prefibrillar Tau oligomers in vitro and in Alzheimer diseaseKristina R Patterson, Christine Remmers, Yifan Fu, et al.
Neuroimage. Clinical|May 20, 2020
TAPAS: A Thresholding Approach for Probability Map Automatic Segmentation in Multiple SclerosisAlessandra M Valcarcel, John Muschelli, Dzung L Pham, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|September 10, 2004
Early N-terminal changes and caspase-6 cleavage of tau in Alzheimer's diseasePeleg M Horowitz, Kristina R Patterson, Angela L Guillozet-Bongaarts, et al.
Annals of Clinical and Translational Neurology|September 2, 2024
B cell and aquaporin-4 antibody relationships with neuromyelitis optica spectrum disorder activityJeffrey L Bennett, Sean J Pittock, Friedemann Paul, et al.
Annals of Clinical and Translational Neurology|October 7, 2023
Inebilizumab reduces neuromyelitis optica spectrum disorder risk independent of FCGR3A polymorphismHo Jin Kim, Orhan Aktas, Kristina R Patterson, et al.
Nature Medicine|September 15, 2021
Cellular and humoral immune responses following SARS-CoV-2 mRNA vaccination in patients with multiple sclerosis on anti-CD20 therapySokratis A Apostolidis, Mihir Kakara, Mark M Painter, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 12, 2023
Differential effects of anti-CD20 therapy on CD4 and CD8 T cells and implication of CD20-expressing CD8 T cells in MS disease activityKoji Shinoda, Rui Li, Ayman Rezk, et al.
Pageof 2